FundedIQ
Biotechnology

Intus Bio: Funding, Investors & Team (Oct 2026)

Intus Bio is utilizing its unique advanced technology to pinpoint bacteria and provide detailed, accurate, and extensive information about the microbiome. They are collaborating with various industries and partners worldwide to conduct innovative research and offer services in health, agriculture, and the environment. Additionally, the company is constantly creating new partnerships, technologies, and uses for its technology.

intusbio.com LinkedIn Farmington, United States 11-50 employees
Bioinformatics Biotechnology Health Care Health Diagnostics B2B
Total raised
$4.2M
Rounds
3
Latest
Undisclosed round
May 2025

Intus Bio has raised $4.2M across 3 funding rounds on record, the most recent an undisclosed round of $1.1M announced in May 2025.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Intus Bio Company Profile and Key Stats

Total funding raised
$4.2M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Undisclosed round
$1.1M in May 2025
Employees
11-50
reported band
Headquarters
Farmington, United States

Latest funding round on record: May 2025.

Intus Bio Funding Rounds

Date
Round
Amount
Undisclosed round
$1.1M
Undisclosed round
$2.0M
Undisclosed round
$1.1M

Intus Bio raised $1.1M in an undisclosed round announced in Nov 2022.

1.7 years later, an undisclosed round of $2.0M was announced in Jul 2024.

10 months later, an undisclosed round of $1.1M was announced in May 2025.

Intus Bio Founders and Leadership Team

Name
Role
Contact
Mark Driscoll
Founder
Locked
Paul Denslow
Founder
Locked
Thomas Jarvie
Founder
—

Contact details for the Intus Bio team: 2 of 3 have an email address on file.

Start 14-day free trial →

Intus Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

Intus Bio's latest round of $1.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Intus Bio in Biotechnology and Farmington

Companies Similar to Intus Bio

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Intus Bio Funding FAQs

What does Intus Bio do?

Intus Bio is utilizing its unique advanced technology to pinpoint bacteria and provide detailed, accurate, and extensive information about the microbiome. They are collaborating with various industries and partners worldwide to conduct innovative research and offer services in health, agriculture, and the environment. Additionally, the company is constantly creating new partnerships, technologies, and uses for its technology.

How much funding has Intus Bio raised?

Intus Bio has raised $4.2M across 3 rounds on record. The most recent is an undisclosed round of $1.1M announced in May 2025.

When did Intus Bio last raise funding?

Intus Bio's most recent funding round on record is an undisclosed round of $1.1M, announced in May 2025.

Who founded Intus Bio?

FundedIQ lists Mark Driscoll (Founder), Paul Denslow (Founder), Thomas Jarvie (Founder) at Intus Bio.

Where is Intus Bio headquartered?

Intus Bio is based in Farmington, Connecticut, United States.

How many employees does Intus Bio have?

Intus Bio is in the 11-50 employee band.

How does Intus Bio's funding compare to other Biotechnology startups?

Intus Bio's latest round of $1.1M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Intus Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Intus Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.